Both circulating CD4+ and CD8+ T cells from HCC patients exhibited reduced capacity to produce IFN-γ (P < 0.05 compared with those from HD, n = 12, Figure 4(a)). The gene discussed is IFNG; the disease is hepatocellular carcinoma.